Two doses of mRNA vaccine elicit cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant
R. Kotaki, Y. Adachi, S. Moriyama, T. Onodera, S. Fukushi, T. Nagakura, K. Tonouchi, K. Terahara, L. Sun, T. Takano, A. Nishiyama, M. Shinkai, K. Oba, F. Nakamura-Uchiyama, H. Shimizu, , Y. Takahashi
The paper shows that two doses of mRNA vaccine generate cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant, which are retained and contribute to enhanced antibody responses after a third dose.
bioRxiv · Dec 24, 2021 · PreprintImmunology